XT
AGIO icon

XTX Topco’s Agios Pharmaceuticals AGIO Stock Holding History

XTX Topco’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87M Sell
50,366
-110,514
-69% -$3.35M 0.02% 1173
2026
Q1 		$5.44M Buy
160,880
+114,841
+249% +$3.26M 0.09% 246
2025
Q4 		$1.25M Buy
+46,039
New +$1.62M 0.03% 866
2025
Q2 		– Sell
-13,801
Closed -$404K – 2297
2025
Q1 		$404K Buy
13,801
+4,529
+49% +$150K 0.02% 1186
2024
Q4 		$305K Buy
9,272
+943
+11% +$44.3K 0.03% 1200
2024
Q3 		$370K Buy
8,329
+2,996
+56% +$136K 0.03% 1051
2024
Q2 		$230K Buy
+5,333
New +$192K 0.02% 1139
2024
Q1 		– Sell
-9,013
Closed -$201K – 1786
2023
Q4 		$201K Sell
9,013
-1,191
-12% -$26.7K 0.04% 964
2023
Q3 		$253K Buy
10,204
+2,641
+35% +$69.9K 0.04% 850
2023
Q2 		$214K Buy
+7,563
New +$188K 0.04% 959

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

XTX Topco's AGIO Position: Q2 2026 in Review

XTX Topco reduced its Agios Pharmaceuticals (AGIO) stake by 69% in Q2 2026, selling an estimated $3.35M and leaving 50,366 shares worth $1.87M. The position accounts for 0.02% of the portfolio, ranked #1173.

XTX Topco first reported a position in AGIO in Q2 2023 and has held it in 10 quarters since. The position peaked at $5.44M in Q1 2026. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • XTX Topco held 50,366 shares of Agios Pharmaceuticals worth $1.87M as of Q2 2026.
  • XTX Topco sold 110,514 Agios Pharmaceuticals shares in Q2 2026, an estimated $3.35M.
  • Agios Pharmaceuticals made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1173 holding.
  • XTX Topco first reported a position in Agios Pharmaceuticals in Q2 2023 and has held it in 10 quarters since.
  • XTX Topco's Agios Pharmaceuticals position peaked at $5.44M in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.